Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy
Transcriptome Analysis of Natural Killer Cells in Response to Newcastle Disease Virus Infected Hepatocellular Carcinoma Cells
Immune responses elicited by ssRNA(-) oncolytic viruses in the host and in the tumor microenvironment
The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma
Personalized dendritic cell vaccination in cancer therapy: An evidence-based research study
Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma
Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality
From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy
Inhibition of Tumor Growth and Metastasis by Newcastle Disease Virus Strain P05 in a Breast Cancer Mouse Model
Anti-TNFR2 enhanced the antitumor activity of a new HMGN1/3M-052 stimulated dendritic cell vaccine in a mouse model of colon cancer
Immunotherapy in breast cancer: an overview of current strategies and perspectives
Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
Tumor cell vaccine combined with Newcastle disease virus promote immunotherapy of lung cancer
Glioblastoma treatment slowly moves towards change: novel druggable targets and translational horizons in 2022
Stefaan van Gool ist Herausgeber einer Sonderausgabe im Journal of Molecular Sciences
[Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma]
Modulated electrohyperthermia in locally advanced cervical cancer: Results of an observational study of 95 patients